blooming
2026-09-14 · Latest update
3,773 doctors/specialists at 2,754 hospitals are waiting for you
Doctors chosen by Bloomers
Fresh updates for Bloomers
ER-100’s developer reported early results in three people with glaucoma. This is an early safety trial—not a cosmetic procedure or an available anti-aging treatment.
Source: Life Biosciences · 개발사 발표2026-10-08 View source ↗Korea · Launch announcementLilly Korea announced a June 10 launch of 12.5 mg and 15 mg Mounjaro. Higher doses are not suitable for everyone; prescribing suitability and local stock need checking with a healthcare provider.
Source: 뉴스핌 · 한국릴리 발표 보도2026-06-09 View source ↗US · US approvalThe FDA approved a 7.2 mg formulation for adults with obesity or qualifying overweight. Gastrointestinal effects and altered skin sensation were reported. US approval does not establish Korean approval or availability.
Source: 미국 FDA2026-03-19 View source ↗US · US launchNovo Nordisk has launched oral Wegovy in the US, adding a prescription option for eligible adults who prefer tablets. Korean availability is separate, and suitability requires clinical assessment.
Source: Novo Nordisk US · 제조사 발표2026-01-05 View source ↗Briefs by blooming · Reviewed